US blood testing company cuts workforce by 40%BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5474 (Published 07 October 2016) Cite this as: BMJ 2016;355:i5474
- Michael McCarthy
The controversial US biotechnology company Theranos, which is currently facing federal sanctions, has announced that it will close its clinical laboratories, shut its retail wellness centers, and lay off 40% of its workforce.
Theranos came under scrutiny last year when reports emerged that the company was using its technology to run only a fraction of the blood tests it conducted and was instead relying on traditional devices made by other companies to process the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial